WA
CRL icon

Winfield Associates’s Charles River Laboratories CRL Stock Holding History

Winfield Associates’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-35
Closed -$4K – 239
2017
Q4 		$4K Hold
35
– – ﹤0.01% 547
2017
Q3 		$4K Hold
35
– – ﹤0.01% 514
2017
Q2 		$4K Buy
35
+30
+600% +$2.76K ﹤0.01% 556
2017
Q1 		$0 Hold
5
– – ﹤0.01% 761
2016
Q4 		$0 Sell
5
-5
-50% -$380 ﹤0.01% 741
2016
Q3 		$1K Hold
10
– – ﹤0.01% 599
2016
Q2 		$1K Buy
+10
New +$824 ﹤0.01% 594

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Winfield Associates's CRL Position: Q1 2018 in Review

Winfield Associates sold out of Charles River Laboratories (CRL) in Q1 2018, closing a stake of 35 shares — an estimated $4K sold.

Winfield Associates first reported a position in CRL in Q2 2016 and held it in 7 quarters. The position peaked at $4K in Q4 2017. 333 funds tracked by Wall St. Rank hold CRL as of Q1 2018.

  • Winfield Associates reported no remaining Charles River Laboratories position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 35 Charles River Laboratories shares in Q1 2018, an estimated $4K.
  • Winfield Associates first reported a position in Charles River Laboratories in Q2 2016 and held it in 7 quarters.
  • Winfield Associates's Charles River Laboratories position peaked at $4K in Q4 2017.
  • 333 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.